ARCHIVES

FDA Advisory Committee Recommends Approval Of Ifosfamide as Third Line Therapy For Testicular Cancer

This article is from The Cancer Letter archive.

Vol. 14 No. 18 | April 29, 1988

Download PDF Visit The Full Archive

Related Articles

Klausner To Serve As Advisor On Bioterrorism For NAS.

January 4, 2002

Voluntary Organizations: ACS to consider targeting Research In Prostate Cancer

November 1, 1996

Harold Varmus Nominated For NIH Director; Selection Wins Support of Biomedical Community

August 13, 1993

Long-Term Estrogen Use May Increase Ovarian Cancer Risk

April 27, 2001

HHS Forms Rural Task Force To Study, Improve Programs.

July 27, 2001

Prevention Clinical Trials Heads Greenwalk Priority Lists For ‘86

February 8, 1985